Literature DB >> 16570308

Clinical electrophysiological characterization of the acquired neuromyotonia phenotype of autoimmune peripheral nerve hyperexcitability.

Paul Maddison1, Kerry R Mills, John Newsom-Davis.   

Abstract

Acquired autoimmune neuromyotonia is regarded as part of the spectrum of peripheral nerve hyperexcitability disorders. We aimed to use clinical neurophysiological measurements to study the extent, distribution, and characteristics of spontaneous motor unit potentials in 11 patients with acquired neuromyotonia. Investigations revealed that most spontaneous discharges recorded were motor unit, or partial motor unit potentials of normal size. Bursts of motor unit potentials arose more commonly from distal portions of the peripheral nerve and had abnormal absolute and relative refractory periods. Spontaneous discharges in some patients occurred in semirhythmic bursts in certain muscles. No patient had neurophysiological abnormalities detectable in first-order neurons of the central nervous system when using transcranial magnetic stimulation to estimate the threshold for corticomotor excitation and determine central motor conduction time. Only patients with coexistent myasthenia gravis had neurophysiologically detectable defects in neuromuscular transmission. The pathogenic region of abnormality in peripheral nerve hyperexcitability disorders therefore seems to lie within the terminal branches of peripheral motor nerves.

Entities:  

Mesh:

Year:  2006        PMID: 16570308     DOI: 10.1002/mus.20536

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  5 in total

1.  A possible mechanism of repetitive firing of myelinated axon.

Authors:  Alexander G Dimitrov
Journal:  Pflugers Arch       Date:  2009-02-10       Impact factor: 3.657

2.  Neuromyotonia Confined to Faciobulbar Muscles in a Patient with Myasthenia Gravis.

Authors:  Dimitrios Parissis; Panagiotis Ioannidis; Georgios Papadopoulos; Dimitrios Karacostas
Journal:  Mov Disord Clin Pract       Date:  2017-02-01

3.  Autoimmune channelopathies of the nervous system.

Authors:  Kleopas A Kleopa
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

4.  Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study.

Authors:  M Gastaldi; A De Rosa; M Maestri; E Zardini; S Scaranzin; M Guida; P Borrelli; O E Ferraro; V Lampasona; R Furlan; S R Irani; P Waters; B Lang; A Vincent; E Marchioni; R Ricciardi; D Franciotta
Journal:  Eur J Neurol       Date:  2019-03-25       Impact factor: 6.089

5.  Myasthenia in acquired neuromyotonia.

Authors:  Jung-Ick Byun; Hye-Jin Moon; Yoon-Ho Hong
Journal:  J Clin Neurol       Date:  2014-01-06       Impact factor: 3.077

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.